MedPage Today | FDA Panel Says J&J's Birth Control Patch Benefits Outweigh Risks RTT News (RTTNews) - Reports in the media Friday said Johnson & Johnson (JNJ: News ) 's Ortho Evra birth control patch was determined by an FDA Advisory panel to provide benefits that outweighed the risk of blood clotting. The advice is not binding on the FDA. ... < br />FDA panel backs birth control patch despite risks Birth Control Patch Should Stay on Market, Panel Says FDA panel backs birth control patch despite risks |
Sunday, 11 December 2011
FDA Panel Says J&J's Birth Control Patch Benefits Outweigh Risks - RTT News
kapitonragomo.blogspot.com
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment